Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$13.11 - $17.02 $155,655 - $202,078
-11,873 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$15.35 - $19.29 $4,298 - $5,401
280 Added 2.42%
11,873 $196,000
Q4 2021

Feb 09, 2022

BUY
$18.5 - $21.59 $8,639 - $10,082
467 Added 4.2%
11,593 $223,000
Q3 2021

Nov 12, 2021

BUY
$20.27 - $22.67 $4,317 - $4,828
213 Added 1.95%
11,126 $231,000
Q1 2021

May 14, 2021

BUY
$19.31 - $22.07 $4,402 - $5,031
228 Added 2.13%
10,913 $215,000
Q4 2020

Feb 16, 2021

BUY
$16.8 - $20.21 $7,543 - $9,074
449 Added 4.39%
10,685 $211,000
Q3 2020

Nov 12, 2020

BUY
$16.71 - $19.06 $3,124 - $3,564
187 Added 1.86%
10,236 $180,000
Q1 2020

May 13, 2020

BUY
$12.22 - $17.99 $122,798 - $180,781
10,049 New
10,049 $151,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.